Pharmaceutical services as a tool to improve outcomes in patients with cardiovascular diseases

Damian Swieczkowski1, Mariusz Mogielnicki2, Piotr Merks3

  • 1First Department of Cardiology, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland; Department of Pharmaceutical Technology, Faculty of Pharmacy, Ludwig Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland.

Insights

Community pharmacy services improve cardiovascular patient outcomes like adherence and blood pressure control. Developing evidence-based models and interprofessional collaboration are key to enhancing pharmaceutical care effectiveness.

Area of Science:

  • Cardiovascular medicine
  • Clinical pharmacy
  • Public health

Background:

  • Major adverse cardiovascular outcomes remain high despite available treatments.
  • Community pharmacy services offer potential benefits for cardiovascular patients.
  • Predicting the impact of pharmaceutical interventions is challenging.

Purpose of the Study:

  • To highlight the impact of clinical pharmacy activities on cardiovascular patient outcomes.
  • To emphasize the need for evidence-based models in pharmaceutical care.
  • To identify areas for improvement in pharmaceutical services for cardiovascular diseases.

Main Methods:

  • Review of existing literature on clinical pharmacy and cardiovascular care.
  • Analysis of factors influencing the effectiveness of community pharmacy interventions.
  • Discussion of the role of health literacy and patient-provider communication.

Main Results:

  • Pharmaceutical care in community settings positively affects adherence, blood pressure, cholesterol, and health literacy.
  • Factors like time spent and communication quality influence intervention outcomes.
  • Interprofessional collaboration and pharmacoeconomic analyses are crucial for advancement.

Conclusions:

  • Pharmaceutical care provides significant benefits to cardiovascular patients and the healthcare system.
  • Developing evidence-based models and enhancing interprofessional collaboration are essential next steps.
  • Further research using real-world data is recommended to optimize pharmaceutical services.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
470
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
564
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
391